Next Pharmaceuticals Wins Industry Award for Business Achievement
Recognized for 240% Growth in 2012
Salinas, California - January 18, 2013 - Nutrition Business Journal announced on Friday its 2012 Business Achievement Award winners. Next Pharmaceuticals won in the growth category, having grown 240% in 2012. In total, 300 nominations were received from the public and reviewed for companies’ contributions to the industry.
“We feel very fortunate to have customers and partners throughout the industry who share our goals and collaborative approach,” said Regan Miles, President of Next Pharmaceuticals. “We would not have seen such success this past year without their support.”
During 2012, Next Pharmaceuticals expanded its partnership efforts, working closely with customers to support their growth. New studies on the company’s branded ingredients were conducted, one of which will have the results announced next month. Media accolades from top health print publications and the country’s leading health television program helped continue to spread the popularity of the products, particularly Relora®. Next Pharmaceuticals also credited its success to its proprietary ingredients that continue to perform well for customers and the breakthrough science on which they are based.
Founded in1997, Next Pharmaceuticals provides patented, science-based natural ingredients for healthy living products in the dietary supplement, food and beverage industries. Next has successfully developed six patented and proprietary plant extracts in addition to Chromulin®, a new, safer form of the essential trace mineral chromium.
Next products help consumers cope with many of today’s most prevalent and chronic health issues, significantly expanding the choices for self-care products while providing consumer brands with powerful product differentiation.
Next proprietary formulations include Relora® for stress, stress-related eating and weight management; Seditol® for improved more restful sleep; Nexrutine® for inflammation due to over-exertion and exercise; Citri-Z® for heart health; Flavoxine® for balanced cholesterol levels; Citrofen® for joint mobility and comfort; and Chromulin® for balanced blood sugar . For more information, visit www.nextpharmaceuticals.com.
Media Contact:
Ashley Beleny, Environmental Relations PR
Office: 831-649-2334/ Mobile: 937-974-8564 / ashley@enviro-rel.com
Tags:
